Roseanna M. Petrovic

Statistics

Publications

Citations

350

H-Index

Active since

2013

Affiliations

King's College London(Current)

King's College Hospital NHS Foundation Trust

Eastbourne District General Hospital

Kings Health Partners

Imperial College London

Roseanna M. Petrovic is an author at King's College London specializing in chimeric antigen receptor t-cell therapy, immunotherapy, and cancer immunotherapy.

ORCID

Publications per year

2013–2022

Publications

Preclinical In Vivo Modeling of Cytokine Release Syndrome Induced by ErbB-Retargeted Human T Cells: Identifying a Window of Therapeutic Opportunity?

Sjoukje J. C. van der Stegen, David M. Davies, Scott Wilkie et al. · The Journal of Immunology · 2013 · 128 citations

Life Sciences, Immunology, Oncology +17

Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells

Lynsey M. Whilding, Ana C. Parente‐Pereira, Tomasz Zabinski et al. · Molecular Therapy · 2017 · 77 citations · Full text

Medicine, Cancer Biology, Oncology +17

CAR T-cell immunotherapy of MET-expressing malignant mesothelioma

Thivyan Thayaparan, Roseanna M. Petrovic, Daniela Achkova et al. · OncoImmunology · 2017 · 74 citations · Full text

Medicine, Immunology, Oncology +17

Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells

Sjoukje J. C. van der Stegen, Pieter L. Lindenbergh, Roseanna M. Petrovic et al. · Nature Biomedical Engineering · 2022 · 71 citations · Full text

Life Sciences, Cell Biology, Immunology +14

1–4 of 4